- $91.63bn
- $90.66bn
- $14.91bn
- 99
- 29
- 87
- 83
Annual balance sheet for Lam Research, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 28th | 2021 June 27th | 2022 June 26th | 2023 June 25th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,710 | 5,729 | 3,658 | 5,375 | 5,848 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,097 | 3,026 | 4,314 | 2,823 | 2,519 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 10,854 | 11,652 | 12,285 | 13,228 | 12,883 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,246 | 1,477 | 1,874 | 2,099 | 2,463 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 14,559 | 15,892 | 17,196 | 18,782 | 18,745 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,162 | 3,528 | 4,565 | 4,185 | 4,338 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 9,387 | 9,865 | 10,917 | 10,571 | 10,205 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,172 | 6,027 | 6,278 | 8,210 | 8,539 |
Total Liabilities & Shareholders' Equity | 14,559 | 15,892 | 17,196 | 18,782 | 18,745 |
Total Common Shares Outstanding |